CEO: | Lindy Durrant |
CFO: | Sath Nirmalananthan |
Deputy Chairman: | Susan Clement Davies |
Non-Executive Chairman: | Jean-Michel Cosséry |
Non-Executive Dir: | Martin Diggle , Ursula Ney |
Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
Website: | http://www.scancell.co.uk/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B63D3314 |
Currency | UK Pounds |
Share Price | 9.60p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 17.00 |
52 Week Low | 8.15 |
Volume | 148,854 |
Shares Issued | 927.98m |
Market Cap | £89.09m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
14:45 | 124,469 @ 9.45p |
12:56 | 1,000 @ 9.40p |
12:48 | 750 @ 9.50p |
12:40 | 21,000 @ 9.50p |
12:19 | 100 @ 9.50p |
CEO | Lindy Durrant |
CFO | Sath Nirmalananthan |
You are here: research